Literature DB >> 3387032

Hexose monophosphate shunt enzymes in lung tumors from normal and glucose-6-phosphate-dehydrogenase-deficient subjects.

S Dessì1, B Batetta, R Cherchi, R Onnis, M Pisano, P Pani.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate, dehydrogenase the key enzymes of the hexose monophosphate shunt pathway, were measured in both surrounding and tumoral lung tissues from normal and G6PD-deficient subjects. A significant increase of these enzymatic activities in tumoral tissue was found not only in G6PD-normal patients, but also in G6PD-deficient patients with very low or nonmeasurable G6PD activity in both erythrocytes and normal lung tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3387032     DOI: 10.1159/000226624

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

1.  Overexpression of G6PD is associated with poor clinical outcome in gastric cancer.

Authors:  Jixu Wang; Weijie Yuan; Zhikang Chen; Shaobin Wu; Jinxiang Chen; Jie Ge; Futao Hou; Zihua Chen
Journal:  Tumour Biol       Date:  2011-10-20

2.  Transcriptional control of cellular metabolism by mTOR signaling.

Authors:  Jessica L Yecies; Brendan D Manning
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

Review 3.  Heme oxygenase in neonatal lung injury and repair.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 4.  mTOR links oncogenic signaling to tumor cell metabolism.

Authors:  Jessica L Yecies; Brendan D Manning
Journal:  J Mol Med (Berl)       Date:  2011-02-08       Impact factor: 4.599

5.  Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells.

Authors:  B Batetta; R R Bonatesta; F Sanna; M Putzolu; M F Mulas; M Collu; S Dessì
Journal:  Cell Prolif       Date:  2002-06       Impact factor: 6.831

Review 6.  Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma.

Authors:  Marta Anna Kowalik; Amedeo Columbano; Andrea Perra
Journal:  Front Oncol       Date:  2017-05-11       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.